Protocol

Moxidectin in Onchocerciasis: Ongoing Clinical Trial Protocols 1

MDGH-MOX-3001: Safety and efficacy of annual or biannual doses of moxidectin or ivermectin for onchocerciasis​(Target: approx. 1,000 participants)​‍

MDGH-MOX-3001: Safety and efficacy of annual or biannual doses of moxidectin or ivermectin for onchocerciasis​(Target: approx. 1,000 participants)​‍

English version
French version

Stay up to date

Follow our work by signing up for our newsletter.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.